Fully integrated chemistry platform
Next-generation linker and payload chemistry enabling customized drug conjugation and optimized release at the target site.
State of the art capabilities allowing for a fully integrated process from A to Z…
We provide end-to-end capabilities for the seamless development of V-Body-based therapeutics, including:
- Antibody engineering & optimization – Developing highly specific, stable, and manufacturable candidates.
- Drug conjugate development – Integrating advanced linker/payload technologies.
- Preclinical & clinical development – Ensuring a smooth transition to regulatory approval.
This fully integrated approach accelerates the translation of cutting-edge science into transformative treatments.
Allowing to derisk next-generation drug candidate for FIH in less than 2 years
We are establishing a fully integrated drug development ecosystem, covering every stage from:
- Target discovery & validation
- Antibody selection & optimization
- Therapeutic candidate development
- Preclinical validation & optimization
- Clinical translation & regulatory approval
This comprehensive approach ensures that each step is optimized for efficiency, safety, and efficacy, bringing innovative treatments closer to patients, faster.
